People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Importance of Defining Recurrence in Hepatocellular Carcinoma: Local or Both Local and Other Intrahepatic Recurrences? The following represents disclosure information provided by the author of this ...

The liver is located under the diaphragm and connected to the right shoulder via the phrenic nerve. If the cancer cells or ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and ...

Statins, commonly used to lower cholesterol, may significantly reduce the risk of liver cancer in patients with chronic liver disease, a new study suggests. Researchers found that statin use decreased ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.